Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1 8Phase 1/2 2Phase NA 1Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Colonic Neoplasms 7Colorectal Neoplasms 6Rectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Liver Neoplasms 2Head and Neck Neoplasms 2Hand-Foot Syndrome 2Adenomatous Polyposis Coli 2Smoking 1Pancreatic Neoplasms 1Pain, Postoperative 1Pain 1Nasopharyngeal Carcinoma 1Lymphoma, Follicular 1Lung Neoplasms 1Influenza, Human 1Drug-Related Side Effects and Adverse Reactions 1Breast Neoplasms, Male 1Agnosia 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 67Cisplatin 57Paclitaxel 42Radiotherapy 35Pemetrexed 34Gemcitabine 31Docetaxel 31Etoposide 25pembrolizumab 21Vinorelbine 20Erlotinib Hydrochloride 13Magnetic Resonance Spectroscopy 12Gefitinib 11Specimen Handling 10Radiosurgery 10Drug Therapy 10Bevacizumab 10durvalumab 9Nivolumab 9Vinblastine 6Topotecan 6Surgical Procedures, Operative 6Cyclophosphamide 6atezolizumab 5Standard of Care 5Platinum 5Immunoglobulin G 5Ifosfamide 5Disulfides 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lung Neoplasms × Celecoxib × Clear all
NCT01041781 2018-07-23

Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Terminated
313 enrolled 14 charts
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡